What is wrong with the AstraZeneca vaccine?

Posted on

I noted this report from Politico this morning (and as ever, I do suggest subscribing, not least because it is free and very good):

Health Secretary Sajid Javid [has said that] the U.K. has secured 114 million more doses to arrive over the next two years, made up of 60 million Moderna jabs and 54 million Pfizer/BioNTech doses. The government had already closed deals for 100 million extra jabs from Pfizer, Novavax and Sanofi.

What I immediately noticed is that AstraZeneca is not on that list. Actually, as they also note, it only now seems to feature on the list of vaccines being donated to developing countries. As they say:

Government officials stressed last night that Britain will donate 100 million doses to countries in need by mid-2022. Plans are currently in place to redistribute 50 million AstraZeneca jabs and 20 million Janssen doses.

So, whilst the UK has enough doses now for everyone to be jabbed six times (unless you're in Scotland when it is jagged six times) we are only slowly getting up to speed with developing country rollouts, but at far too slow a pace to protect us and with a vaccine now dropped in the UK.

Three questions then.

Why has AZ been dropped for use in the UK?

What were the equivalent death rates for those with AZ and Pfizer the first time round? The answer is known, without a doubt, but has never been published. Why not?

And, if AZ is apparently no good for us any more, why is it being given away?

To fuel my concern I note this Tweet from the highly respected Prof Ravi Gupta yesterday:

60% effectiveness is, as I understand it, the minimum threshold required for a vaccine to be considered as such. AZ crept in, but is that really good enough for us to be giving it away now when there may be better products available?

I am worried that an international vaccine programme based on a product we will no longer buy is really not good enough and will rebound badly for everyone.

What is necessary is that the truth about this vaccine's effectiveness in the UK be told. Then an informed decision can be made and proper judgement be formed. I really don't think that is too much to ask for now.


Thanks for reading this post.
You can share this post on social media of your choice by clicking these icons:

You can subscribe to this blog's daily email here.

And if you would like to support this blog you can, here: